Abstract
Comparison of Provider Assessed and Patient Reported Outcome Measures of Acute Skin Toxicity during a Phase III Trial of Mometasone Cream versus Placebo during Breast RT from the North Central Cancer Treatment Group (N06C4)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Paper Title
Journal
Date
